Use of Biosimilar Medications in Oncology.

Zeina Nahleh Gary H Lyman Richard L Schilsky Douglas E Peterson Scott T Tagawa Mariana Chavez Mac GregorR Bryan RumbleShilpi Gupta

Published in: JCO oncology practice (2022)

The use of biosimilars might provide competitive, lower-cost alternatives to biologics used in cancer care, and specific mention in ASCO guidelines and other evidence products is supported where appropriate.

Keyphrases

palliative care
clinical practice